<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title><![CDATA[ Clinical Supply RSS Feed]]></title>
        <link>https://www.pharmalogisticsiq.com/rss/categories/clinical-supply</link>
        <description><![CDATA[ &lt;p class=&quot;small_gray&quot;&gt;The clinical supply chain is unique to itself, distributing to hundreds of study sites, often world-wide. The rapid growth of biological based pharmaceuticals is apparent in clinical trials today, creating even greater demands on clinical logistics practitioners handling biological specimens such as DNA and RNA. Cold Chain IQ provides industry insights exploring how the efficient supply of clinical materials and IMPs is the lynchpin to ensuring patients are dosed on time and clinical trials run efficiently.&lt;/p&gt; ]]></description>
        <language>en</language>
        <pubDate>Mon, 25 May 2026 22:51:35 +0000</pubDate>
        <atom:link href="https://www.pharmalogisticsiq.com/rss/categories/clinical-supply" rel="self" type="application/rss+xml"/>
                    <item>
                <title><![CDATA[Access to Medicines Index 2022: AstraZeneca on patent transparency]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/news/gsk-jj-and-astrazeneca-top-access-to-medicines-ranking?utm_medium=RSS</link>
                <description><![CDATA[ Pharma Logistics IQ speaks to AstraZeneca’s VP of Sustainability and Access to Healthcare about ranking third on the Access to Medicines Index ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/news/gsk-jj-and-astrazeneca-top-access-to-medicines-ranking?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:19:14 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[As cholera cases surge, key vaccine manufacturer to stop production]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/news/as-cholera-cases-surge-key-vaccine-manufacturer-to-stop-production?utm_medium=RSS</link>
                <description><![CDATA[ Global stockpile of cholera vaccines to be impacted as key manufacturer stops production ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/news/as-cholera-cases-surge-key-vaccine-manufacturer-to-stop-production?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:19:14 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Ask the expert: Single-use systems]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/interviews/ask-the-expert-single-use-systems?utm_medium=RSS</link>
                <description><![CDATA[ Pharma Logistics IQ asks Sanofi’s Head of Procurement for Asia to explain the benefits of shifting to single-use systems ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/interviews/ask-the-expert-single-use-systems?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:20:25 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Single-use systems: how to overcome challenges and mitigate risk in bioprocessin...]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/reports/single-use-systems-how-to-overcome-challenges-and-mitigate-risk-in-bioprocessing?utm_medium=RSS</link>
                <description><![CDATA[ This Pharma Logistics IQ report explores the emergence of single-use systems and their benefits compared to reusable equipment ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/reports/single-use-systems-how-to-overcome-challenges-and-mitigate-risk-in-bioprocessing?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:20:25 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[AstraZeneca joins efforts to boost global Covid-19 vaccine access]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/articles/astrazeneca-joins-efforts-to-boost-global-covid-19-vaccine-access?utm_medium=RSS</link>
                <description><![CDATA[ AstraZeneca launches mobile clinics to boost access to Covid-19 vaccines ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/articles/astrazeneca-joins-efforts-to-boost-global-covid-19-vaccine-access?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:29:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Big pharma signs up to provide vital cancer therapies to lower income countries]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/articles/big-pharma-signs-up-to-provide-vital-cancer-therapies-to-lower-income-countries?utm_medium=RSS</link>
                <description><![CDATA[ Following Pfizer, more pharma giants are stepping up to provide access to vital medication where it is needed ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/articles/big-pharma-signs-up-to-provide-vital-cancer-therapies-to-lower-income-countries?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:29:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Pfizer to supply all its medicines to low-income countries for no profit]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/articles/pfizer-to-supply-all-its-medicines-to-low-income-countries-for-no-profit?utm_medium=RSS</link>
                <description><![CDATA[ Pfizer’s new initiative will provide low-income countries with medicines on a not-for-profit basis ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/articles/pfizer-to-supply-all-its-medicines-to-low-income-countries-for-no-profit?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:29:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Morocco’s role in the medicinal supply chain for Africa and beyond]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/articles/moroccos-role-in-medicinal-supply-chain-for-africa-and-beyond?utm_medium=RSS</link>
                <description><![CDATA[ Pharma Logistics IQ speaks to the Moroccan government about the role the country’s pharma sector has in the international supply chain ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/articles/moroccos-role-in-medicinal-supply-chain-for-africa-and-beyond?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:29:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[This week’s big story: Stop banning exports of medical products, report says]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/news/this-weeks-big-story-stop-banning-exports-of-medical-products-report-says?utm_medium=RSS</link>
                <description><![CDATA[ Pharma Logistics IQ dives into a new report calling for international cooperation and an end to banning medical exports. ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/news/this-weeks-big-story-stop-banning-exports-of-medical-products-report-says?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:19:14 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[This week’s big story: BioNTech&#039;s new facility for vaccine production in Africa]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/news/this-weeks-big-story-biontechs-modular-facility-for-vaccine-production-in-africa?utm_medium=RSS</link>
                <description><![CDATA[ BioNTech is planning its first scalable modular facility to produce vaccines for African countries ]]></description>
                <author><![CDATA[ leila.hawkins@iqpc.com (Leila Hawkins) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/news/this-weeks-big-story-biontechs-modular-facility-for-vaccine-production-in-africa?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:19:14 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[How patient-centricity enhances resilience in pharma supply chains]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/articles/how-patient-centricity-enhances-resilience-in-pharma-supply-chains?utm_medium=RSS</link>
                <description><![CDATA[ Discover four benefits of engineering a patient-centric supply chain to increase operational resilience during the Covid-19 pandemic ]]></description>
                <author><![CDATA[  () ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/articles/how-patient-centricity-enhances-resilience-in-pharma-supply-chains?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:29:24 +0000</pubDate>
            </item>
                    <item>
                <title><![CDATA[Responding to Covid-19 in pharmaceutical supply chains]]></title>
                <link>https://www.pharmalogisticsiq.com/clinical-supply/reports/responding-covid-19-pharmaceutical-supply-chains?utm_medium=RSS</link>
                <description><![CDATA[ Explore strategic solutions to mitigate short- and long-term supply chain disruption and receive exclusive access to an interview with the President and Chief Executive Officer for Inheris BioPharma ]]></description>
                <author><![CDATA[  (Pharma  Logistics IQ) ]]></author>
                <guid>https://www.pharmalogisticsiq.com/clinical-supply/reports/responding-covid-19-pharmaceutical-supply-chains?utm_medium=RSS</guid>
                <pubDate>Tue, 29 Aug 2023 15:29:24 +0000</pubDate>
            </item>
            </channel>
</rss>